Kronos Bio Stock Discussion

$Kronos Bio(KRON.US)$
NEWS
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Kronos Bio announced new data from its Phase 1/2 trial of KB-0742, presented at the 2024 ASCO Annual Meeting. KB-0742 showed a manageable safety profile with no grade 3/4 neutropenia observed. Dose linear pharmacokinetics were consistent up to 80mg, and increased target engagement was noted at higher doses. The 80mg four-days-on, t...

$Kronos Bio(KRON.US)$ Kronos Bio Says Phase 1b Portion Of Phase 1b/2 Lanraplenib Study Does Not Support Continuing To Phase 2

Gainers:
• $Cogent Biosciences(COGT.US)$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions(UNVR.US)$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts(MTN.US)$ +6% (In reaction to earnings/guidance)
• $BeiGene(BGNE.US)$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...

$Westwater Resources(WWR.US)$  go buy these IPO I mentioned few days ago $Kronos Bio(KRON.US)$  and $iHuman(IH.US)$

$Kronos Bio(KRON.US)$  Another new IPO to keep eye for anything bio related in 2020 due to COVID is a good investment